Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Research Center, |
RCV000626082 | SCV000746706 | likely pathogenic | Sporadic porphyria cutanea tarda | 2020-05-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001851502 | SCV002169014 | uncertain significance | not provided | 2021-03-29 | criteria provided, single submitter | clinical testing | Experimental studies have shown that this variant affects UROD protein function (PMID: 8644733). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has been observed in individual(s) with autosomal recessive hepatoerythropoietic porphyria (PMID: 8644733). ClinVar contains an entry for this variant (Variation ID: 71). This variant is present in population databases (rs121918061, ExAC 0.003%). This sequence change replaces tyrosine with cysteine at codon 311 of the UROD protein (p.Tyr311Cys). The tyrosine residue is highly conserved and there is a large physicochemical difference between tyrosine and cysteine. |
OMIM | RCV000000089 | SCV000020232 | pathogenic | Hepatoerythropoietic porphyria | 1996-04-01 | no assertion criteria provided | literature only |